-
1
-
-
84864748513
-
Alarmins: awaiting a clinical response
-
Chan JK, Roth J, Oppenheim JJ, et al. Alarmins: awaiting a clinical response. J Clin Invest. 2012; 122: 2711-9.
-
(2012)
J Clin Invest
, vol.122
, pp. 2711-2719
-
-
Chan, J.K.1
Roth, J.2
Oppenheim, J.J.3
-
2
-
-
0036957367
-
HMGB1 as a cytokine and therapeutic target
-
Yang H, Wang H, Czura CJ, et al. HMGB1 as a cytokine and therapeutic target. J Endotoxin Res. 2002; 8: 469-72.
-
(2002)
J Endotoxin Res
, vol.8
, pp. 469-472
-
-
Yang, H.1
Wang, H.2
Czura, C.J.3
-
3
-
-
0034664791
-
HMG-1 as a mediator of acute lung inflammation
-
Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol. 2000; 165: 2950-4.
-
(2000)
J Immunol
, vol.165
, pp. 2950-2954
-
-
Abraham, E.1
Arcaroli, J.2
Carmody, A.3
-
4
-
-
79960726338
-
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls
-
Hou C, Zhao H, Liu L, et al. High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med. 2011; 17: 807-15.
-
(2011)
Mol Med
, vol.17
, pp. 807-815
-
-
Hou, C.1
Zhao, H.2
Liu, L.3
-
5
-
-
61849089739
-
Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity
-
Yoshizaki A, Komura K, Iwata Y, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol. 2009; 29: 180-9.
-
(2009)
J Clin Immunol
, vol.29
, pp. 180-189
-
-
Yoshizaki, A.1
Komura, K.2
Iwata, Y.3
-
6
-
-
53349099086
-
The role of high mobility group box1 in pulmonary fibrosis
-
Hamada N, Maeyama T, Kawaguchi T, et al. The role of high mobility group box1 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2008; 39: 440-7.
-
(2008)
Am J Respir Cell Mol Biol
, vol.39
, pp. 440-447
-
-
Hamada, N.1
Maeyama, T.2
Kawaguchi, T.3
-
7
-
-
84867845975
-
HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage
-
Zhou Y, Jiang YQ, Wang WX, et al. HMGB1 and RAGE levels in induced sputum correlate with asthma severity and neutrophil percentage. Hum Immunol. 2012; 73: 1171-4.
-
(2012)
Hum Immunol
, vol.73
, pp. 1171-1174
-
-
Zhou, Y.1
Jiang, Y.Q.2
Wang, W.X.3
-
8
-
-
77952307233
-
Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease
-
Ferhani N, Letuve S, Kozhich A, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010; 181: 917-27.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 917-927
-
-
Ferhani, N.1
Letuve, S.2
Kozhich, A.3
-
9
-
-
84870523226
-
Molecular pathogenesis of pulmonary arterial hypertension
-
Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest. 2012; 122: 4306-13.
-
(2012)
J Clin Invest
, vol.122
, pp. 4306-4313
-
-
Rabinovitch, M.1
-
10
-
-
31044444627
-
Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease
-
Trad S, Amoura Z, Beigelman C, et al. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease. Arthritis Rheum. 2006; 54: 184-91.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 184-191
-
-
Trad, S.1
Amoura, Z.2
Beigelman, C.3
-
11
-
-
34249784805
-
Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment
-
Proudman SM, Stevens WM, Sahhar J, et al. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Intern Med J. 2007; 37: 485-94.
-
(2007)
Intern Med J
, vol.37
, pp. 485-494
-
-
Proudman, S.M.1
Stevens, W.M.2
Sahhar, J.3
-
12
-
-
0028298825
-
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension
-
Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994; 89: 2722-7.
-
(1994)
Circulation
, vol.89
, pp. 2722-2727
-
-
Petitpretz, P.1
Brenot, F.2
Azarian, R.3
-
14
-
-
33947370516
-
Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis
-
Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest. 2007; 131: 650-6.
-
(2007)
Chest
, vol.131
, pp. 650-656
-
-
Hamada, K.1
Nagai, S.2
Tanaka, S.3
-
15
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006; 129: 746-52.
-
(2006)
Chest
, vol.129
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
-
16
-
-
3142517968
-
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
-
Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004; 59: 574-80.
-
(2004)
Thorax
, vol.59
, pp. 574-580
-
-
Gan, W.Q.1
Man, S.F.2
Senthilselvan, A.3
-
18
-
-
84855467311
-
Inflammation in pulmonary arterial hypertension
-
Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arterial hypertension. Chest. 2012; 141: 210-21.
-
(2012)
Chest
, vol.141
, pp. 210-221
-
-
Price, L.C.1
Wort, S.J.2
Perros, F.3
-
19
-
-
84868283518
-
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension
-
Savai R, Pullamsetti SS, Kolbe J, et al. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012; 186: 897-908.
-
(2012)
Am J Respir Crit Care Med
, vol.186
, pp. 897-908
-
-
Savai, R.1
Pullamsetti, S.S.2
Kolbe, J.3
-
20
-
-
0028282859
-
Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
-
Tuder RM, Groves B, Badesch DB, et al. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am J Pathol. 1994; 144: 275-85.
-
(1994)
Am J Pathol
, vol.144
, pp. 275-285
-
-
Tuder, R.M.1
Groves, B.2
Badesch, D.B.3
-
21
-
-
84902950876
-
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
-
Rabinovitch M, Guignabert C, Humbert M, et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014; 115: 165-75.
-
(2014)
Circ Res
, vol.115
, pp. 165-175
-
-
Rabinovitch, M.1
Guignabert, C.2
Humbert, M.3
-
22
-
-
84871709863
-
[Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease]
-
Cheng Z, Kang Y, Wu QG, et al. [Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease]. Zhonghua Yi Xue Za Zhi. 2011; 91: 2981-4.
-
(2011)
Zhonghua Yi Xue Za Zhi
, vol.91
, pp. 2981-2984
-
-
Cheng, Z.1
Kang, Y.2
Wu, Q.G.3
-
23
-
-
84873509875
-
High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4
-
Bauer EM, Shapiro R, Zheng H, et al. High mobility group box 1 contributes to the pathogenesis of experimental pulmonary hypertension via activation of Toll-like receptor 4. Mol Med. 2012; 18: 1509-18.
-
(2012)
Mol Med
, vol.18
, pp. 1509-1518
-
-
Bauer, E.M.1
Shapiro, R.2
Zheng, H.3
-
24
-
-
0037769813
-
Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
-
Fiuza C, Bustin M, Talwar S, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003; 101: 2652-60.
-
(2003)
Blood
, vol.101
, pp. 2652-2660
-
-
Fiuza, C.1
Bustin, M.2
Talwar, S.3
-
25
-
-
0029062419
-
Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension
-
Humbert M, Monti G, Brenot F, et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995; 151: 1628-31.
-
(1995)
Am J Respir Crit Care Med
, vol.151
, pp. 1628-1631
-
-
Humbert, M.1
Monti, G.2
Brenot, F.3
-
26
-
-
77956390581
-
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
-
Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010; 122: 920-7.
-
(2010)
Circulation
, vol.122
, pp. 920-927
-
-
Soon, E.1
Holmes, A.M.2
Treacy, C.M.3
-
27
-
-
0037092565
-
CX(3)C chemokine fractalkine in pulmonary arterial hypertension
-
Balabanian K, Foussat A, Dorfmuller P, et al. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002; 165: 1419-25.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 1419-1425
-
-
Balabanian, K.1
Foussat, A.2
Dorfmuller, P.3
-
29
-
-
33644824392
-
Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension
-
Itoh T, Nagaya N, Ishibashi-Ueda H, et al. Increased plasma monocyte chemoattractant protein-1 level in idiopathic pulmonary arterial hypertension. Respirology. 2006; 11: 158-63.
-
(2006)
Respirology
, vol.11
, pp. 158-163
-
-
Itoh, T.1
Nagaya, N.2
Ishibashi-Ueda, H.3
-
30
-
-
36248952716
-
Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension
-
Sanchez O, Marcos E, Perros F, et al. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2007; 176: 1041-7.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 1041-1047
-
-
Sanchez, O.1
Marcos, E.2
Perros, F.3
-
31
-
-
84903846674
-
Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension
-
Hoffmann J, Wilhelm J, Marsh LM, et al. Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med. 2014; 190: 98-111.
-
(2014)
Am J Respir Crit Care Med
, vol.190
, pp. 98-111
-
-
Hoffmann, J.1
Wilhelm, J.2
Marsh, L.M.3
-
32
-
-
0023873580
-
Pulmonary vascular structure and function in chronic obstructive pulmonary disease
-
Magee F, Wright JL, Wiggs BR, et al. Pulmonary vascular structure and function in chronic obstructive pulmonary disease. Thorax. 1988; 43: 183-9.
-
(1988)
Thorax
, vol.43
, pp. 183-189
-
-
Magee, F.1
Wright, J.L.2
Wiggs, B.R.3
-
33
-
-
80052178805
-
Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease
-
Noureddine H, Gary-Bobo G, Alifano M, et al. Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res. 2011; 109: 543-53.
-
(2011)
Circ Res
, vol.109
, pp. 543-553
-
-
Noureddine, H.1
Gary-Bobo, G.2
Alifano, M.3
-
34
-
-
0036212004
-
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
-
Santos S, Peinado VI, Ramirez J, et al. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J. 2002; 19: 632-8.
-
(2002)
Eur Respir J
, vol.19
, pp. 632-638
-
-
Santos, S.1
Peinado, V.I.2
Ramirez, J.3
-
35
-
-
29644441337
-
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine
-
Mitola S, Belleri M, Urbinati C, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol. 2006; 176: 12-5.
-
(2006)
J Immunol
, vol.176
, pp. 12-15
-
-
Mitola, S.1
Belleri, M.2
Urbinati, C.3
-
36
-
-
33845649733
-
Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein
-
Porto A, Palumbo R, Pieroni M, et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J. 2006; 20: 2565-6.
-
(2006)
FASEB J
, vol.20
, pp. 2565-2566
-
-
Porto, A.1
Palumbo, R.2
Pieroni, M.3
-
37
-
-
84860794215
-
Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery
-
Hayakawa K, Pham LD, Katusic ZS, et al. Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A. 2012; 109: 7505-10.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 7505-7510
-
-
Hayakawa, K.1
Pham, L.D.2
Katusic, Z.S.3
-
38
-
-
84872298261
-
High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s)
-
Bauer EM, Shapiro R, Billiar TR, et al. High mobility group Box 1 inhibits human pulmonary artery endothelial cell migration via a Toll-like receptor 4- and interferon response factor 3-dependent mechanism(s). J Biol Chem. 2013; 288: 1365-73.
-
(2013)
J Biol Chem
, vol.288
, pp. 1365-1373
-
-
Bauer, E.M.1
Shapiro, R.2
Billiar, T.R.3
-
39
-
-
0035911959
-
The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells
-
Degryse B, Bonaldi T, Scaffidi P, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol. 2001; 152: 1197-206.
-
(2001)
J Cell Biol
, vol.152
, pp. 1197-1206
-
-
Degryse, B.1
Bonaldi, T.2
Scaffidi, P.3
-
40
-
-
84877806447
-
High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK
-
Wang FP, Li L, Li J, et al. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS ONE. 2013; 8: e64373.
-
(2013)
PLoS ONE
, vol.8
, pp. e64373
-
-
Wang, F.P.1
Li, L.2
Li, J.3
-
41
-
-
75749109330
-
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
-
Wagner EF. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis. 2010; 69(Suppl. 1): i86-8.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. i86-i88
-
-
Wagner, E.F.1
-
42
-
-
84898596426
-
Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension
-
Biasin V, Marsh LM, Egemnazarov B, et al. Meprin beta, a novel mediator of vascular remodelling underlying pulmonary hypertension. J Pathol. 2014; 233: 7-17.
-
(2014)
J Pathol
, vol.233
, pp. 7-17
-
-
Biasin, V.1
Marsh, L.M.2
Egemnazarov, B.3
-
43
-
-
84904480132
-
HMGB1 promotes the development of pulmonary arterial hypertension in rats
-
Sadamura-Takenaka Y, Ito T, Noma S, et al. HMGB1 promotes the development of pulmonary arterial hypertension in rats. PLoS ONE. 2014; 9: e102482.
-
(2014)
PLoS ONE
, vol.9
, pp. e102482
-
-
Sadamura-Takenaka, Y.1
Ito, T.2
Noma, S.3
|